Original Literature | Model OverView |
---|---|
Publication
Title
Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides.
Affiliation
Department of Medicine, University of Munster, Germany. heidenr@uni-muenster.de
Abstract
Like all other immune system cells, monocytes and macrophages may undergoapoptotic cell death in response to specific triggers and mediators or as aconsequence of aging. However, factors inducing apoptosis and the involvedcellular and molecular mechanisms are much better investigated and understoodfor lymphocytes. Th2 cell-derived cytokines such as interleukin-4 (IL-4) areable to induce monocyte apoptosis most effectively. This process is preceded bydown-regulation of the CD14 surface receptor. Mediators such aslipopolysaccharide (LPS) suppress and postpone apoptosis in parallel withup-regulation of CD14. Macrophages are rather resistant against apoptoticdamage, and factors able to evoke apoptosis in monocytes are often ineffectivein macrophages. Resistance of macrophages against apoptotic triggers may bebeneficial for inflammatory processes where macrophages are engaged and neededas phagocytes for ingestion and removal of moribund cells. The multifunctionalCD14 receptor of monocytes/macrophages is supposed to be involved in theapoptotic network on both sides: as a surface molecule of monocytes that canpromote survival and antagonize apoptosis and as a recognition receptor ofmacrophages that enables or supports interaction with apoptotic cells.
PMID
10380893
|
Entity
IL-2R complexes
--
MO000000087
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m78
10
infinite
0
TRANSPATH | MO000000087 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IL-1beta
--
MO000016597
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1591
10
infinite
0
TRANSPATH | MO000016597 |
--
CD14
--
MO000018132
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2828
10
infinite
0
InterPro | IPR001611 |
TRANSPATH | MO000018132 |
--
proCaspase-1
--
MO000018229
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m2906
10
infinite
0
InterPro | IPR001309 |
TRANSPATH | MO000018229 |
--
proIL-1beta
--
MO000019449
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m4012
10
infinite
0
InterPro | IPR003297 |
TRANSPATH | MO000019449 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
IL4-IL4R
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
csml-variable:Double
m12
0
infinite
0
--
IL10-IL10R
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m13
0
infinite
0
--
FasL:Fas
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m14
0
infinite
0
--
csml-variable:Double
m15
0
infinite
0
--
LPS:CD14
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
IgM
--
e18
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m18
0
infinite
0
--
NF-kappaB{active}
--
e19
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
NF-kappaB
--
e20
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m20
0
infinite
0
--
anti-CD14
--
e21
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m21
0
infinite
0
--
csml-variable:Double
m22
0
infinite
0
--
Ca2+
--
e23
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
IL-2:IL-2R
--
e24
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m24
0
infinite
0
--
muramyl dipeptide
--
e25
cso30:c:SmallMolecule
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m25
0
infinite
0
--
muramyl peptide:CD14
--
e26
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m26
0
infinite
0
--
peptidoglycan
--
e27
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m27
0
infinite
0
--
peptidoglycan:CD14
--
e28
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m28
0
infinite
0
--
lipoarabinomannan
--
e29
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
e30
--
e30
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m30
0
infinite
0
--
Phospholipids
--
e31
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m31
0
infinite
0
--
Phospholipids:CD14
--
e32
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m32
0
infinite
0
--
p38{p}
--
e33
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
NF-kappaB{active}
--
e34
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
LPS:CD14:TLR2
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
TNF-alpha:TNFR
--
e36
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m38
0
infinite
0
--
csml-variable:Double
m39
0
infinite
0
--
IL-1R
--
e38
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m40
0
infinite
0
--
IL-1:IL-1R
--
e39
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IL-13:IL-13R
--
e40
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m42
0
infinite
0
--
unknown receptor
--
e41
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m43
0
infinite
0
--
phosphatidyl serine
--
e42
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m44
0
infinite
0
--
phosphatidyl serine:unknown receptor
--
e43
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m45
0
infinite
0
--
CD36:alpha5beta3 integrin
--
e44
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m46
0
infinite
0
--
thrombospondin
--
e45
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m47
0
infinite
0
--
thrombospondin:CD36:alpha5beta3 integrin
--
e46
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m48
0
infinite
0
--
CD40L
--
e5
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
CD40L:CD40
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e65
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m65
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c1 : 1
stoichiometry:c2 : 1
m17*m2906*0.1
nodelay
--
0
PMID: 10380893, 9427712 In monocytic THP-1 cells LPS was able to activate caspase-1, a cysteine protease involved in different apoptotic processes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c27 : 1
m14*0.1
nodelay
--
0
PMID: 10380893 It was pointed out that reactive oxygen intermediates (ROI) play a central role as downstream mediators of Fasinduced monocyte apoptosis.
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c39 : 1
stoichiometry:c33 : 1
m2828*m155666*m3985*0.1
nodelay
--
0
PMID: 10380893, 1698311 In 1990 CD14 putative main function as a receptor for LPS was discovered with the help of specific monoclonal antibodies (mAb). PMID: 10380893, 2402637 LPS binds to CD14 in a native state or in aggregates and a 60-kDa serum glycoprotein, named LPS-binding protein (LBP), highly enhances binding to the CD14 receptor.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c36 : 1
stoichiometry:c35 : 1
m17*m19*0.1
nodelay
--
0
PMID: 10380893, 1375269 In murine 70 Z/3 B cells, LPS responsiveness was enhanced 1000-fold as measured by nuclear factor-kB (NF-kB) -regulated rise of IgM expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c40 : 1
stoichiometry:c38 : 1
m20*m17*0.1
nodelay
--
0
PMID: 10380893, 7534294 Gregner et al. could show that LPS signal transduction and LPS clearance or internalization utilized both membrane-bound CD14 (mCD14) and LBP but signal transduction pathways, e.g., NF-kB activation, diverged after the initial complex was formed.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m21*m2828*0.1
nodelay
--
0
PMID: 10380893, 2466895 Ca2+ mobilization in activated monocytes can be induced by the CD14 molecule via cross-linking of anti-CD14 antibody Fc receptors or F(ab)¡Ç2 fragments of secondary antibodies.
p16
p16
cso30:i:ME_ChangeInMaterialConcentration
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c47 : 1
m22*0.1
nodelay
--
0
PMID: 10380893, 2466895 Ca2+ mobilization in activated monocytes can be induced by the CD14 molecule via cross-linking of anti-CD14 antibody Fc receptors or F(ab)¡Ç2 fragments of secondary antibodies.
p17
p17
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c54 : 1
stoichiometry:c59 : 1
stoichiometry:c50 : 1
m12*m24*0.1
nodelay
--
0
PMID: 10380893 This was shown by blocking IL-8 and IL-1b secretion induced by IL-2 with anti-CD14 mAbs as well as by transfecting U937 cells with CD14 cDNA and thus up-regulating monokine synthesis in response to IL-2.
p18
p18
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m1954*m78*0.1
nodelay
--
0
PMID: 10380893 This was shown by blocking IL-8 and IL-1b secretion induced by IL-2 with anti-CD14 mAbs as well as by transfecting U937 cells with CD14 cDNA and thus up-regulating monokine synthesis in response to IL-2.
p19
p19
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c30 : 1
stoichiometry:c41 : 1
stoichiometry:c56 : 1
m93364*m24*0.1
nodelay
--
0
PMID: 10380893 This was shown by blocking IL-8 and IL-1b secretion induced by IL-2 with anti-CD14 mAbs as well as by transfecting U937 cells with CD14 cDNA and thus up-regulating monokine synthesis in response to IL-2. PMID: 10380893 Only IL-4 blocked CD40-dependent rescue from apoptosis, although both cytokines decreased IL-1b synthesis after receptor ligation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m4012*0.1
nodelay
--
0
PMID: 10380893 Cleavage of the IL-1b precursor protein was followed by release of mature IL-1b with putative secondary consequences for the antagonism of cell death.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c62 : 1
stoichiometry:c61 : 1
m25*m2828*0.1
nodelay
--
0
PMID: 10380893, 7534618 purified lipophilic or polysaccharide components such as muramyl dipeptide, peptidoglycan, lipoarabinomannan, or phospholipids interact with CD14, suggesting that CD14 acts not only as a surface receptor for LPS but might function as a polyspecific receptor with broad recognition properties.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c65 : 1
stoichiometry:c64 : 1
m27*m2828*0.1
nodelay
--
0
PMID: 10380893, 7534618 purified lipophilic or polysaccharide components such as muramyl dipeptide, peptidoglycan, lipoarabinomannan, or phospholipids interact with CD14, suggesting that CD14 acts not only as a surface receptor for LPS but might function as a polyspecific receptor with broad recognition properties.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c68 : 1
stoichiometry:c67 : 1
m29*m2828*0.1
nodelay
--
0
PMID: 10380893, 7534618 purified lipophilic or polysaccharide components such as muramyl dipeptide, peptidoglycan, lipoarabinomannan, or phospholipids interact with CD14, suggesting that CD14 acts not only as a surface receptor for LPS but might function as a polyspecific receptor with broad recognition properties.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c6 : 1
stoichiometry:c70 : 1
m31*m2828*0.1
nodelay
--
0
PMID: 10380893, 7534618 purified lipophilic or polysaccharide components such as muramyl dipeptide, peptidoglycan, lipoarabinomannan, or phospholipids interact with CD14, suggesting that CD14 acts not only as a surface receptor for LPS but might function as a polyspecific receptor with broad recognition properties.
p25
p25
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c75 : 1
stoichiometry:c74 : 1
m33*m17*0.1
nodelay
--
0
PMID: 10380893, 7914033, 7992057 Monocyte activation by LPS induces a rapid increase of tyrosine phosphorylation in different proteins belonging to the MAP kinase family such as p38 or ERK.
p26
p26
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m35*m17*0.1
nodelay
--
0
PMID: 10380893, 7914033, 7992057 Monocyte activation by LPS induces a rapid increase of tyrosine phosphorylation in different proteins belonging to the MAP kinase family such as p38 or ERK.
p27
p27
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c88 : 1
stoichiometry:c80 : 1
m93309*m37*0.1
nodelay
--
0
PMID: 10380893 wild-type LPS activated the cytokine production (e.g., TNF-a) and translocated NF-kB in a TLR2-dependent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c81 : 1
m37*0.1
nodelay
--
0
PMID: 10380893 wild-type LPS activated the cytokine production (e.g., TNF-a) and translocated NF-kB in a TLR2-dependent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c89 : 1
stoichiometry:c83 : 1
m19*m37*0.1
nodelay
--
0
PMID: 10380893 wild-type LPS activated the cytokine production (e.g., TNF-a) and translocated NF-kB in a TLR2-dependent manner.
p30
p30
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m3964*m17*0.1
nodelay
--
0
PMID: 10380893 wild-type LPS activated the cytokine production (e.g., TNF-a) and translocated NF-kB in a TLR2-dependent manner.
p32
p32
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c10 : 1
stoichiometry:c29 : 1
stoichiometry:c92 : 1
m17*0.1
nodelay
--
0
PMID: 10380893 Parallel to increased CD14 expression due to LPS administration, apoptosis was inhibited, whereas decreased expression after IL-4 treatment was associated with induction of apoptosis.
p33
p33
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c98 : 1
stoichiometry:c95 : 1
m230*m39*0.1
nodelay
--
0
PMID: 10380893, 7682078 Cytokines such as TNF-a or IL-1 with their well-known effects of enhancing survival of monocytes also increase CD14 expression.
p34
p34
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c16 : 1
stoichiometry:c22 : 1
stoichiometry:c97 : 1
m38*0.1
nodelay
--
0
PMID: 10380893, 7682078 Cytokines such as TNF-a or IL-1 with their well-known effects of enhancing survival of monocytes also increase CD14 expression. PMID: 10380893 Parallel to increased CD14 expression due to LPS administration, apoptosis was inhibited, whereas decreased expression after IL-4 treatment was associated with induction of apoptosis.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
stoichiometry:c101 : 1
m185*m40*0.1
nodelay
--
0
PMID: 10380893, 7682078 Cytokines such as TNF-a or IL-1 with their well-known effects of enhancing survival of monocytes also increase CD14 expression.
p36
p36
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c15 : 1
stoichiometry:c17 : 1
stoichiometry:c102 : 1
m41*0.1
nodelay
--
0
PMID: 10380893, 7682078 Cytokines such as TNF-a or IL-1 with their well-known effects of enhancing survival of monocytes also increase CD14 expression. PMID: 10380893 Parallel to increased CD14 expression due to LPS administration, apoptosis was inhibited, whereas decreased expression after IL-4 treatment was associated with induction of apoptosis.
p38
p38
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
stoichiometry:c107 : 1
m836*m12757*0.1
nodelay
--
0
PMID: 10380893, 7545713 IL-13 can evoke apoptosis consecutively to down-regulation of CD14
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m43*m44*0.1
nodelay
--
0
PMID: 10380893, 1545126, 7595231 Phagocyte receptors for phosphatidylserine (PS) have been further described that bind this phospholipid when it comes from the inner to the outer leaflet of the membranes of cells undergoing apoptosis.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m1837*m5*0.1
nodelay
--
0
PMID: 10380893 Activation of monocytes can also be achieved through the interaction between monocytic CD40 with the CD40 ligand present on activated lymphocytes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m47*m46*0.1
nodelay
--
0
PMID: 10380893, 1688647, 7536797 The first and best established receptor complex comprises the avb3 vitronectin receptor integrin and CD36, which belongs to class B scavenger receptors and can bind thrombospondin.
p5
p5
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c12 : 1
stoichiometry:c13 : 1
m1952*m1947*0.1
nodelay
--
0
PMID: 10380893 Only IL-4 blocked CD40-dependent rescue from apoptosis, although both cytokines decreased IL-1b synthesis after receptor ligation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c23 : 1
stoichiometry:c14 : 1
1.0*0.1
nodelay
--
0
PMID: 10380893 Only IL-4 blocked CD40-dependent rescue from apoptosis, although both cytokines decreased IL-1b synthesis after receptor ligation.
p8
p8
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m2108*m2103*0.1
nodelay
--
0
PMID: 10380893 Only IL-4 blocked CD40-dependent rescue from apoptosis, although both cytokines decreased IL-1b synthesis after receptor ligation.
p9
p9
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m580*m1844*0.1
nodelay
--
0
PMID: 10380893, 7532907 The Fas (APO-1,CD95)/Fas ligand (FasL) system has been established as a central pathway for the induction of lymphocyte apoptosis acting from the cell surface site
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--